EMERGE: Aducanumab (BIIB037) for Early Alzheimer's Disease
Language
Undefined
Purpose: To evaluate treatment of early Alzheimer's disease with the experimental drug aducanumab (BIIB037).
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials